Ariel Hurley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ariel hurley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ariel Hurley Today - Breaking & Trending Today

Avidity Partners Management LP Decreases Stake in Blueprint Medicines Co. (NASDAQ:BPMC)

Avidity Partners Management LP lessened its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 615,000 shares of the biotechnology company’s stock after selling 136,600 shares during the quarter. Blueprint Medicines accounts for approximately 2.1% of Avidity […] ....

United States , Piper Sandler , Ariel Hurley , Stifel Nicolaus , Michael Landsittel , Blueprint Medicines Co , Jump Financial , Securities Exchange Commission , Compass Wealth Management , Headlands Technologies , Blueprint Medicines Corporation , Blueprint Medicines Company Profile , Associates Corp , Avidity Partners Management , Blueprint Medicines , Free Report , Partners Management , Wealth Management , Management Fondsmaeglerselskab , Get Free Report , Exchange Commission , Medicines Corporation , Visit Holdingschannel , Blueprint Medicines Daily ,

Avidity Partners Management LP Has $56.73 Million Stake in Blueprint Medicines Co. (NASDAQ:BPMC)

Avidity Partners Management LP decreased its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 615,000 shares of the biotechnology company’s stock after selling 136,600 shares during the quarter. Blueprint Medicines comprises […] ....

United States , Leerink Partnrs , Ariel Hurley , L Becker Hewes , Associates Corp , Exchange Commission , Blueprint Medicines Corporation , Goldman Sachs Group , Securities Exchange Commission , Headlands Technologies , Jump Financial , Blueprint Medicines Co , Compass Wealth Management , Avidity Partners Management , Blueprint Medicines , Free Report , Partners Management , Wealth Management , Management Fondsmaeglerselskab , Get Free Report , Medicines Corporation , Visit Holdingschannel , Blueprint Medicines Daily ,

Eagle Asset Management Inc. Boosts Stake in Blueprint Medicines Co. (NASDAQ:BPMC)

Eagle Asset Management Inc. raised its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 10.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 231,396 shares of the biotechnology company’s stock after acquiring an additional 22,279 […] ....

United States , Ariel Hurley , Stifel Nicolaus , Piper Sandler , Jeffreyw Albers , Axiom Investors , Exchange Commission , Eagle Asset Management Inc , Brown Advisory Inc , Needham Company , Blueprint Medicines Corporation , Blueprint Medicines Co , Norges Bank , Eagle Asset Management , Blueprint Medicines , Free Report , Asset Management , Management Fondsmaeglerselskab , Brown Advisory , Get Free Report , Director Jeffrey , Medicines Corporation , Visit Holdingschannel , Blueprint Medicines Daily ,

Blueprint Medicines Co. (NASDAQ:BPMC) Forecasted to Earn Q2 2024 Earnings of ($1.40) Per Share

Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Equities researchers at Zacks Research issued their Q2 2024 earnings per share estimates for shares of Blueprint Medicines in a report released on Tuesday, May 14th. Zacks Research analyst A. Chakraborty forecasts that the biotechnology company will earn ($1.40) per share for the quarter. The consensus estimate […] ....

United States , Michael Landsittel , Ariel Hurley , Blueprint Medicines Co , Needham Company , Goldman Sachs Group , Zacks Research , American Century Companies Inc , Vanguard Group Inc , Rafferty Asset Management , Securities Exchange Commission , Blueprint Medicines Corporation , Blueprint Medicines , Free Report , Blueprint Medicine , Get Free Report , Medicines Trading Down , Asset Management , Century Companies , Vanguard Group , Exchange Commission , Medicines Corporation , Blueprint Medicines Daily ,

Equities Analysts Offer Predictions for Blueprint Medicines Co.'s Q2 2024 Earnings (NASDAQ:BPMC)

Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Analysts at Zacks Research issued their Q2 2024 earnings per share estimates for Blueprint Medicines in a report released on Tuesday, May 14th. Zacks Research analyst A. Chakraborty anticipates that the biotechnology company will post earnings of ($1.40) per share for the quarter. The consensus estimate for […] ....

United States , Stifel Nicolaus , Michael Landsittel , Ariel Hurley , Zacks Research , Goldman Sachs Group , Blueprint Medicines Co , Covestor Ltd , Blueprint Medicines Corporation , Headlands Technologies , Financial Services Group Inc , Securities Exchange Commission , Analysts At Zacks Research , Compass Wealth Management , Cutler Group , Blueprint Medicines , Free Report , Blueprint Medicine , Get Free Report , Exchange Commission , Services Group , Medicines Corporation , Blueprint Medicines Daily ,